【作者】 李敏；

【导师】 郭丽英；

【作者基本信息】 新疆医科大学 ， 外科学， 2010， 硕士

【摘要】 目的:本文通过统计804例乳腺癌患者人表皮生长因子受体-2(human epidermal growth factor receptor-2,Her-2),探讨乳腺癌Her-2表达与临床病理特征的相关性及临床意义。方法:收集1995年1月-2009年12月于我院进行治疗,病理证实为原发性乳腺癌,Her-2资料完整的女性患者共804例。采用回顾性分析的方法,统计804例乳腺癌患Her-2的表达,应用秩和检验及秩相关分析法,分析Her-2与多种相关因素,包括乳腺癌原发肿瘤的大小、淋巴结转移、病理分级、病理类型、分期、年龄、月经状态、雌激素受体ER、孕激素受体PR等临床病理特征相关性。结果:乳腺癌组织中Her-2表达在肿块大小、TNM分期分组间有统计学差异(P<0.05)。以上结果进一步行秩相关检验,得出乳腺癌肿块大小、TNM分期、预后均与Her-2表达呈正相关。Her-2表达在淋巴结转移数目、ER、PR不同有统计学差异(P<0.05)。但进一步行秩相关检验无明显相关性。Her-2表达不同年龄、月经状态、组织学分级与Her-2均无统计学差异(P>0.05)。Her-2表达不同无瘤及复发转移有统计学差异(P<0.05)。结论:Her-2基因表达在肿瘤大小、临床TNM分期、预后有关,通过Her-2检测能有效指导病情评估及判断预后。Her-2表达在不同ER、PR表达中无明显相关性,但Her-2过表达时ER、PR表达较弱。Her-2与ER、PR两者的联合检测有利于乳腺癌的治疗方案的选择。Her-2阳性表达、淋巴结无转移术后应给予加强辅助治疗。更多还原

【Abstract】 Objective: In our experiment, the expression of Her-2 in breast cancer tissue of 804 cases were studied to analyze its correlation with tumor clinical pathology features and evaluate prognosis. Materials and methods: Collect the clinical data of 804 breast cancer cases who has treated in our hospital and final diagnosis is primary breast cancer by pathology result since 1995 to 2009. The correlation-ship of these three kinds of oncogenes with tumor biological behaviour such as the size, ER, PRl, ympho node metastasis、patho-histological type and rank, stage were studied in Kruskal Wallis test of statistics and analyzed in grade related data method. The correlation-ship among Her-2 was also studied in order to confirm correlation-ship of Her-2 with their clinical pathology features in identical breast cancer tissue.Result:Breast cancer specimens were positive for Her-2 ,which correlated with the factors such as TNM stage , prognosis and tumor size(P<0.05).norelated with hormone receptor status (ER、PR) patho-histological type and rank、lymphonodes metastasis、location、age、menstruate(P<0.05)。Conclusion: Breast cancer Her-2 expression correlated with the factors such as TNM stage,prognosis and tumor size,which can evaluate prognosis. Measurement of Her-2, ER and PR in the breast cancers can be used to guide clinical treatment.Her-2 positive expression、no lymphonodes metastasis patients should be intensive subsidiary treated.更多还原